16th Annual NATA Symposium

16th Annual NATA Symposium, Prague 2015The 16th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will be held at the Prague Congress Centre, 5. kvetna 65, 140 21 Prague 4 (www.kcp.cz), Czech Republic.
Go to entrance 5.


The annual NATA symposium will provide a unique opportunity for stimulating and constructive exchanges across different specialities involved in patient blood management.

The results of major, recently published or completed trials will be presented and discussed:

  • The Age of Blood Evaluation (ABLE) Randomised Controlled Trial
  • The Transfusion Requirements in Septic Shock (TRISS) Trial
  • Long-Term Mortality in the Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
  • Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: FIB-PPH Study
  • Liberal or Restrictive Transfusion after Cardiac Surgery: TITRe2 Study


The final programme, which includes practical information, the scientific programme, the list of accepted abstracts and the schedule for poster visits, the industry-sponsored programme, the list of exhibitors and the exhibition floor plan, is available in PDF format.


The speaker and poster abstracts of the 16th Annual NATA Symposium are now avaiable online in Transfusion Medicine.

More information on the Annual NATA Symposium

Follow NATA on LinkedIn and Twitter

Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter

News from the Industry: White Paper – Red Cell Salvage: Current Status

Intraoperative Red Cell Salvage (RCS) was introduced in the early 1980s and rapidly gained clinical acceptance. Early RCS was done without cell washing, but washed RCS became the standard of care in cardiac surgery and other procedures.

RCS gained popularity because it did not carry the risk of transfusion-transmitted diseases, notably HIV and hepatitis B and C, and decreased demand for allogeneic blood. While both of these benefits are still true today, the increased safety profile of allogeneic transfusion as well as the presence of stable blood inventories have diminished their importance.

Nevertheless, strong clinical and economic reasons remain to use RCS. This white paper addresses these issues.
Read more on this

News

Anaesthesia Supplement on ‘Transfusion, Thrombosis and Management of Bleeding’

Anaesthesia, the journal of the Association of Anaesthetists of Great Britain & Ireland, announces the publication of a special open-access supplement on Transfusion, Thrombosis and Management of Bleeding, to coincide with the UK launch of Patient Blood Management in the NHS.

A collaboration between anaesthetists, haematologists, surgeons and others, this supplement pulls together state-of-the-art research and recommendations into a comprehensive guide. World-renowned specialists have contributed a series of detailed reviews and debates.
Read more on this

From the Literature

Apr 18, 2015

Published: Apr 2015

Pisani A, Riccio E, Sabbatini M, Andreucci M, Del Rio A, Visciano B

Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.
Nephrol Dial Transplant 2015;30:645-652.

#

NATA REVIEW:
In this randomised, open-label trial, 99 patients with non-dialysis chronic kidney disease (ND-CKD) and iron...
REVIEW by:
M. Muñoz

Published: Mar 2015

Carson JL, Sieber F, Cook DR, et al.

Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial.
Lancet 2015;385:1183-1189.

#

NATA REVIEW:
Carson and colleagues report the long-term results of the FOCUS trial published in 2011. In FOCUS, 2016 elderly...
REVIEW by:
J.-F. Hardy

Published: Mar 2015

Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency.
Eur Heart J 2015;36:657-668.

#

NATA REVIEW:
The authors studied the benefits and safety of long-term intravenous iron therapy in patients with heart failure...
REVIEW by:
L. T. Goodnough

Published: Mar 2015

Murphy GJ, Pike K, Rogers CA, et al.

Liberal or restrictive transfusion after cardiac surgery.
N Engl J Med 2015;372:997-1008.

#

NATA REVIEW:
Murphy et al. conducted a very large (2003 patients) randomised trial comparing a liberal (threshold...
REVIEW by:
J.-F. Hardy

Published: Feb 2015

Holcomb JB, Tilley BC, Baraniuk S, et al.

Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
JAMA 2015;313:471-482.

#

NATA REVIEW:
Holcomb and colleagues lead the way in high-quality trauma resuscitation research, setting the standard for...
REVIEW by:
J. Stensballe

Published: Feb 2015

Reed GW, Kumar A, Guo J, et al.

Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify Pre-Op TIMI 45 – a pilot study.
Clin Cardiol 2015;38:92-98.

#

NATA REVIEW:
The authors performed a proof-of-principle pilot study indicating that point-of-care platelet function testing...
REVIEW by:
S. Kozek-Langenecker